ConductScience.org, home

Paper2559

Comparison between two antibody populations in the EBV system: anti-MA versus neutralizing antibody activity.

de Schryver A and 3 others. Int J Cancer, 1976. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Comparison between two antibody populations in the EBV system: anti-MA versus neutralizing antibody activity. Papers, record 2559. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2559

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison between two antibody populations in the EBV system: anti-MA versus neutralizing antibody activity.
PubMed
Journal
Int J Cancer
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.37
iCite
Revised in PubMed
2019-07-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Schryver AA
2Rosén AA
3Gunvén PP
4Klein GG

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
Burkitt LymphomaMajor topic
Herpesvirus 4, HumanMajor topic
Nasopharyngeal NeoplasmsMajor topic
Animals
Cell Membrane
Hot Temperature
Hydrogen-Ion Concentration
Immunoglobulin G
Neutralization Tests

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
6248876Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6248876PubMed
6182100Neutralization of lymphocyte immortalization by different strains of Epstein-Barr virus with a murine monoclonal antibody.Infect Immun1982https://conductscience.org/library/papers/6182100PubMed
195004Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.J Exp Med1977https://conductscience.org/library/papers/195004PubMed
81320Papain solubilization of the Epstein-Barr virus-induced membrane antigen.J Virol1978https://conductscience.org/library/papers/81320PubMed
70292Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.Clin Exp Immunol1977https://conductscience.org/library/papers/70292PubMed
19029Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients.Br J Cancer1977https://conductscience.org/library/papers/19029PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2559

GET https://conductscience.org/api/papers/v1/2559/authors